pubmed-article:1560699 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0019360 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0001367 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0012403 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0020811 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:1560699 | lifeskim:mentions | umls-concept:C0991555 | lld:lifeskim |
pubmed-article:1560699 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:1560699 | pubmed:dateCreated | 1992-5-12 | lld:pubmed |
pubmed-article:1560699 | pubmed:abstractText | Both topical 40% idoxuridine in dimethylsulfoxide (IDU) and oral acyclovir (ACV) are useful in herpes zoster (HZ). This is the first clinical trial which compares the efficacy of both drugs in the course of the disease and in the prevention of post-herpetic neuralgia (PHN). | lld:pubmed |
pubmed-article:1560699 | pubmed:language | spa | lld:pubmed |
pubmed-article:1560699 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1560699 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1560699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1560699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1560699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1560699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1560699 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1560699 | pubmed:month | Feb | lld:pubmed |
pubmed-article:1560699 | pubmed:issn | 0025-7753 | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:CastroAA | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:DíazJ LJL | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:ArmijoMM | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:CrucesMM | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:CamachoFF | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:MascaróJ MJM | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:AliagaAA | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:FernándezJ... | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:LedoAA | lld:pubmed |
pubmed-article:1560699 | pubmed:author | pubmed-author:IglesiasLL | lld:pubmed |
pubmed-article:1560699 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1560699 | pubmed:day | 22 | lld:pubmed |
pubmed-article:1560699 | pubmed:volume | 98 | lld:pubmed |
pubmed-article:1560699 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1560699 | pubmed:authorsComplete | N | lld:pubmed |
pubmed-article:1560699 | pubmed:pagination | 245-9 | lld:pubmed |
pubmed-article:1560699 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:meshHeading | pubmed-meshheading:1560699-... | lld:pubmed |
pubmed-article:1560699 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1560699 | pubmed:articleTitle | [A topical solution of 40% idoxuridine in dimethyl sulfoxide compared to oral acyclovir in the treatment of herpes zoster. A double-blind multicenter clinical trial]. | lld:pubmed |
pubmed-article:1560699 | pubmed:affiliation | Hospital General Universitario, Valencia. | lld:pubmed |
pubmed-article:1560699 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1560699 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:1560699 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:1560699 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:1560699 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:1560699 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1560699 | lld:pubmed |